Aviptadil/Phentolamine mesylate

阿肽地尔/甲磺酸酚妥拉明

Report date: 2025/06/09 13:58:33

Base Information

Drug NameAviptadil/Phentolamine mesylate
Drug Alias Name阿肽地尔和甲磺酸酚妥拉明Aviptadil-Phentolamine Mesilate mixtPhentolamine Mesilate and Aviptadil阿肽地尔/酚妥拉明甲磺酸酚妥拉明/阿肽地尔 +[13] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAdrenergic receptors antagonistsVasoactive intestinal polypeptide receptor 1 agonistsVasoactive intestinal polypeptide receptor 2 agonists
TargetsAdrenergic receptorsVasoactive intestinal polypeptide receptor 1Vasoactive intestinal polypeptide receptor 2
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryDenmark
Original Approved Date1998/01/01
Country/TerritoryDenmarkUnited Kingdom
CombinationsYes Phentolamine MesilateAviptadil
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSenetek
China Registration ClassN/A

Develop Information

Active CompaniesSenetekNRx Pharmaceuticals IncQuantum Leap Healthcare Collaborative
Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeG04BE30
Related LinksN/A